Development of glycan specific lectin based immunoassay for detection of prostate specific antigen

International Journal of Biological Macromolecules

Volumn 86, Issue , 2016, Pages 468-480

  Bhanushali, Paresh B ^a,b   Badgujar, Shamkant B ^a,c   Tripathi, Mukesh M ^a   Gupta, Sanjeev ^a   Murthy, Vedang ^d   Krishnasastry, Musti V ^e   Puri, Chander P ^b  

^a Yashraj Biotechnology Ltd   (India)

^b MGM Institute of Health Sciences   (India)

^c NATIONAL INSTITUTE FOR RESEARCH IN REPRODUCTIVE HEALTH   (India)

^d TATA MEMORIAL HOSPITAL   (India)

^e NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

Biomarkers; Glycosylation; Lectin based immunoassay; Prostate cancer; Prostate specific antigen

Indexed keywords

CASEIN; GELATIN; GLYCAN; LECTIN; MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN; PROTEINASE; POLYSACCHARIDE;

ADSORPTION CHROMATOGRAPHY; AFFINITY CHROMATOGRAPHY; AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ANTIGEN BINDING; ANTIGEN DETECTION; ANTIGEN PURIFICATION; ARTICLE; BINDING AFFINITY; BIOTINYLATION; CANCER PROGNOSIS; CLINICAL ARTICLE; COLUMN CHROMATOGRAPHY; ELECTROPHORESIS; ELISA KIT; ENZYME ACTIVITY; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOASSAY; LIMIT OF DETECTION; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; PROSTATE CANCER; SURFACE PLASMON RESONANCE; BLOOD; CHEMISTRY; ENZYME SPECIFICITY; IMMUNOLOGY; METABOLISM; PROCEDURES; SPERM;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; GLYCOSYLATION; HUMANS; IMMUNOASSAY; LECTINS; POLYSACCHARIDES; PROSTATE-SPECIFIC ANTIGEN; SEMEN; SUBSTRATE SPECIFICITY; SURFACE PLASMON RESONANCE;

EID: 84956914930     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2016.01.110     Document Type: Article

References (46)

1. Fukushima K., Satoh T., Baba S., Yamashita K. α1,2-Fucosylated and β-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer. Glycobiology 2010, 20:452-460.
2. Pettersson K., Piironen T., Seppälä M., Liukkonen L., Christensson A., Matikainen M.T., Suonpää M., Lövgren T., Lilja H. Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex. Clin. Chem. 1995, 41:1480-1488.
3. Bélanger A., van Halbeek H., Graves H.C., Grandbois K., Stamey T.A., Huang L., Poppe I., Labrie F. Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard. Prostate 1995, 27:187-197.
4. Peracaula R., Tabarés G., Royle L., Harvey D.J., Dwek R.A., Rudd P.M., Llorens de R. Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins. Glycobiology 2003, 13:457-470.
5. Noldus J., Chen Z., Stamey T.A. Isolation and characterization of free form prostate specific antigen (f-PSA) in sera of men with prostate cancer. J. Urol. 1997, 158:1606-1609.
6. Recker F., Kwiatkowski M.K., Piironen T., Pettersson K., Goepe M., Tscholl R. Free-to-total prostate-specific antigen (PSA) ratio improves the specificity for detecting prostate cancer in patients with prostatism and intermediate PSA levels. Br. J. Urol. 1998, 81:532-538.
7. Ohyama C., Hosono M., Nitta K., Oh-eda M., Yoshikawa K., Habuchi T., Arai Y., Fukuda M. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy. Glycobiology 2004, 14:671-679.
8. Tajiri M., Ohyama C., Wada Y. Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach. Glycobiology 2008, 18:2-8.
9. Ohyama C., Koie T., Yoneyama T., Tobisawa Y. Quantification of prostate cancer-associated aberrant glycosylation of prostate-specific antigen. Glycoscience: Biology and Medicine 2014, 1-6. Springer, Japan. T. Endo, P.H. Seeberger, G.W. Hart, C. Wong, N. Taniguchi (Eds.).
10. Lilja H., Ulmert D., Vickers A.J. Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat. Rev. Cancer 2008, 8:268-278.
11. Donohue M.J., Satterfield M.B., Dalluge J.J., Welch M.J., Girard J.E., Bunk D.M. Capillary electrophoresis for the investigation of prostate-specific antigen heterogeneity. Anal. Biochem. 2005, 339:318-327.
12. Garrido-Medina R., Díez-Masa J.C., Frutos de M. CE methods for analysis of isoforms of prostate-specific antigen compatible with online derivatization for LIF detection. Electrophoresis 2011, 32:2036-2043.
13. Wang M.C., Valenzuela L.A., Murphy G.P., Chu T.M. A simplified purification procedure for human prostate antigen. Oncology 1982, 39:1-5.
14. Jung K., Brux B., Lein M., Rudolph B., Kristiansen G., Hauptmann S., Schnorr D., Loening S.A., Sinha P. Molecular forms of prostate-specific antigen in malignant and benign prostatic tissue: biochemical and diagnostic implications. Clin. Chem. 2000, 46:47-54.
15. Jette D.C., Kreutz F.T., Malcolm B.A., Wishart D.S., Noujaim A.A., Suresh M.R. Epitope' mapping of prostate-specific antigen with monoclonal antibodies. Clin. Chem. 1996, 42:1961-1969.
16. Lorenzetti S., Marcoccia D., Narciso L., Mantovani A. Cell viability and PSA secretion assays in LNCaP cells: a tiered in vitro approach to screen chemicals with a prostate-mediated effect on male reproduction within the ReProTect project. Reprod. Toxicol. 2010, 30:25-35.
17. Acevedo B., Perera Y., Torres E., Pentón D., Ayala M., Gavilondo J. Fast and novel purification method to obtain the prostate specific antigen (PSA) from human seminal plasma. Prostate 2006, 66:1029-1036.
18. Garrido-Medina R., Farina-Gomez N., Diez-Masa J.C., Frutos de M. Immunoaffinity chromatographic isolation of prostate-specific antigen from seminal plasma for capillary electrophoresis analysis of its isoforms. Anal. Chim. Acta 2014, 820:47-55.
19. Lilja H., Laurell C.B. The predominant protein in human seminal coagulate. Scand. J. Clin. Lab. Invest. 1985, 45:635-641.
20. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
21. Jones S.L., Cox J.C., Pearson J.E. Increased monoclonal antibody ascites production in mice primed with Freund's incomplete adjuvant. J. Immunol. Methods 1990, 129:227-231.
22. Hoogenraad N., Helman T., Hoogenraad J. The effect of pre-injection of mice with pristane on ascites tumour formation and monoclonal antibody production. J. Immunol. Methods 1983, 61:317-320.
23. Mueller U.W., Hawes C.S., Jones W.R. Monoclonal antibody production by hybridoma growth in Freund's adjuvant primed mice. J. Immunol. Methods 1986, 87:193-196.
24. Hober S., Nord K., Linhult M. Protein A chromatography for antibody purification. J. Chromatogr. B 2007, 848:40-47.
25. Grodzki A.C., Berenstein E. Antibody purification: affinity chromatography-protein A and protein G Sepharose. Methods Mol. Biol. 2010, 588:33-41.
26. Bayat A.A., Yeganeh O., Ghods R., Zarnani A.H., Ardekani R.B., Mahmoudi A.R., Mahmoudian J., Noutash F.H., Tehrani M.J. Production and characterization of a murine monoclonal antibody against human ferritin. Avicenna J. Med. Biotechnol. 2013, 5:212-219.
27. Kawinski E., Levine E., Chadha K. Thiophilic interaction chromatography facilitates detection of various molecular complexes of prostate-specific antigen in biological fluids. Prostate 2002, 50:145-153.
28. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
29. Kar P., Agnihotri S.K., Sharma A., Sachan R., Bhatt M.L., Sachdev M. A protocol for stripping and reprobing of Western blots originally developed with colorimetric substrate TMB. Electrophoresis 2012, 33:3062-3065.
30. Khan M.R., Blain J.A., Petterson J.D.E. Extracellular protease of Mucor pusithis. J. Appl. Environ. Microbiol. 1979, 37:719-724.
31. Heussen C., Dowdle E.B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulphate and copolymerized substrates. Anal. Biochem. 1980, 102:196-202.
32. Chait B.T., Kent S.B.H. Weighing naked proteins: practical, high-accuracy mass measurement of peptides and proteins. Science 1992, 257:1885-1894.
33. Coombs G.S., Bergstrom R.C., Pellequer J.L., Baker S.I., Navre M., Smith M.M., Tainer J.A., Madison E.L., Corey D.R. Substrate specificity of prostate-specific antigen (PSA). Chem. Biol. 1998, 5:475-488.
34. Matsumura K., Higashida K., Hata Y., Kominami J., Nakamura-Tsuruta S., Hirabayashi J. Comparative analysis of oligosaccharide specificities of fucose-specific lectins from Aspergillus oryzae and Aleuria aurantia using frontal affinity chromatography. Anal. Biochem. 2009, 386:217-221.
35. Shibuya N., Goldstein I.J., Broekaert W.F., Nsimba-Lubaki M., Peeters B., Peumans W.J. The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence. J. Biol. Chem. 1987, 262:1596-1601.
36. Knibbs R.N., Goldstein I.J., Ratcliffe R.M., Shibuya N. Characterization of the carbohydrate binding specificity of the leukoagglutinating lectin from Maackia amurensis. Comparison with other sialic acid-specific lectins. J. Biol. Chem. 1991, 266:83-88.
37. Christoph G., Donald L.J. Effective glycoanalysis with Maackia amurensis lectins requires a clear understanding of their binding specificities. Glycobiology 2011, 21:988-993.
38. Murthy V., Rishi A., Gupta S., Kannan S., Mahantshetty U., Tongaonkar H., Bakshi G., Prabhash K., Bhanushali P., Shinde B., Inamdar N., Shrivastava S. Clinical impact of prostate specific antigen (PSA) inter-assay variability on management of prostate cancer. Clin. Biochem. 2015, (in press). 10.1016/j.clinbiochem.2015.10.013.
39. Chen Z., Chen H., Stamey T.A. Prostate specific antigen in benign prostatic hyperplasia: purification and characterization. J. Urol. 1997, 157:2166-2170.
40. Denmeade S.R., Lou W., Lovgren J., Malm J., Lilja H., Isaacs J.T. Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigen. Cancer Res. 1997, 57:4924-4930.
41. Leinonen J., Zhang W.M., Stenman U.H. Complex formation between PSA isoenzymes and protease inhibitors. J. Urol. 1996, 155:1099-1103.
42. Gallardo-Williams M.T., Maronpot R.R., Wine R.N., Brunssen S.H., Chapin R.E. Inhibition of the enzymatic activity of prostate-specific antigen by boric acid and 3-nitrophenyl boronic acid. Prostate 2003, 54:44-49.
43. Végvári A., Rezeli M., Welinder C., Malm J., Lilja H., Marko-Varga G., Laurell T. Identification of prostate specific antigen (psa) isoforms in complex biological samples utilizing complementary platforms. J. Proteom. 2010, 73:1137-1147.
44. Yoneyama T., Ohyama C., Hatakeyama S., Narita S., Habuchi T., Koie T., Mori K., Hidari K.I., Yamaguchi M., Suzuki T., Tobisawa Y. Measurement of aberrant glycosylation of prostate specific antigen can improve specificity in early detection of prostate cancer. Biochem. Biophys. Res. Commun. 2014, 448:390-396.
45. Varki A., Cummings R., Esko J., Freeze H., Hart G., Marth J. Essentials of Glycobiology 1999, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
46. Poon T.C.W., Mok T.S.K., Chan A.T.C., Chan C.M.L., Leong V., Tsui S.T.H., Leung T.W.T., Leung T.W., Wong H.T., Ho S.K., Johnson P.J. Quantification and utility of monosialylated alpha-fetoprotein in the diagnosis of hepatocellular carcinoma with nondiagnostic serum total alpha-fetoprotein. Clin. Chem. 2002, 48:1021-1027.